CN108997425A - 一种制备高含量磷霉素氨丁三醇的方法 - Google Patents
一种制备高含量磷霉素氨丁三醇的方法 Download PDFInfo
- Publication number
- CN108997425A CN108997425A CN201710419776.0A CN201710419776A CN108997425A CN 108997425 A CN108997425 A CN 108997425A CN 201710419776 A CN201710419776 A CN 201710419776A CN 108997425 A CN108997425 A CN 108997425A
- Authority
- CN
- China
- Prior art keywords
- tromethamine
- phosphonomycin
- fosfomycin
- alcohol
- solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- YMDXZJFXQJVXBF-STHAYSLISA-N fosfomycin Chemical compound C[C@@H]1O[C@@H]1P(O)(O)=O YMDXZJFXQJVXBF-STHAYSLISA-N 0.000 title claims abstract description 110
- 229960000308 fosfomycin Drugs 0.000 title claims abstract description 71
- 238000000034 method Methods 0.000 title claims description 23
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 claims abstract description 48
- 229960000281 trometamol Drugs 0.000 claims abstract description 45
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 claims abstract description 36
- 239000012043 crude product Substances 0.000 claims abstract description 33
- 238000002425 crystallisation Methods 0.000 claims abstract description 26
- 230000008025 crystallization Effects 0.000 claims abstract description 25
- 239000000047 product Substances 0.000 claims abstract description 25
- 238000006243 chemical reaction Methods 0.000 claims abstract description 24
- 101100059652 Mus musculus Cetn1 gene Proteins 0.000 claims abstract description 23
- 101100059655 Mus musculus Cetn2 gene Proteins 0.000 claims abstract description 23
- ODALAXKSIBESFV-PXRNWTNJSA-N [(2r,3s)-3-methyloxiran-2-yl]phosphonic acid;(1r)-1-phenylethanamine Chemical compound C[C@@H]1O[C@@H]1P(O)(O)=O.C[C@@H](N)C1=CC=CC=C1 ODALAXKSIBESFV-PXRNWTNJSA-N 0.000 claims abstract description 23
- 238000001914 filtration Methods 0.000 claims abstract description 18
- 229940098779 methanesulfonic acid Drugs 0.000 claims abstract description 18
- 238000003756 stirring Methods 0.000 claims abstract description 13
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 claims abstract description 11
- 238000001816 cooling Methods 0.000 claims abstract description 10
- 230000001476 alcoholic effect Effects 0.000 claims abstract description 9
- 238000001291 vacuum drying Methods 0.000 claims abstract description 9
- 238000007670 refining Methods 0.000 claims abstract description 7
- 238000010189 synthetic method Methods 0.000 claims abstract description 4
- 239000002994 raw material Substances 0.000 claims abstract description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 103
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical group OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 81
- 235000019441 ethanol Nutrition 0.000 claims description 46
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 37
- 238000002360 preparation method Methods 0.000 claims description 17
- 150000003839 salts Chemical class 0.000 claims description 13
- 150000001298 alcohols Chemical class 0.000 claims description 9
- 239000002904 solvent Substances 0.000 claims description 7
- 239000007788 liquid Substances 0.000 claims description 2
- LBLYYCQCTBFVLH-UHFFFAOYSA-N 2-Methylbenzenesulfonic acid Chemical compound CC1=CC=CC=C1S(O)(=O)=O LBLYYCQCTBFVLH-UHFFFAOYSA-N 0.000 claims 1
- QZJIMDIBFFHQDW-LMLSDSMGSA-N Fosfomycin tromethamine Chemical compound C[C@@H]1O[C@@H]1P(O)([O-])=O.OCC([NH3+])(CO)CO QZJIMDIBFFHQDW-LMLSDSMGSA-N 0.000 claims 1
- RQEUFEKYXDPUSK-UHFFFAOYSA-N 1-phenylethylamine Chemical class CC(N)C1=CC=CC=C1 RQEUFEKYXDPUSK-UHFFFAOYSA-N 0.000 abstract description 24
- 239000000243 solution Substances 0.000 description 52
- 229960000935 dehydrated alcohol Drugs 0.000 description 26
- 229960004756 ethanol Drugs 0.000 description 23
- 239000012535 impurity Substances 0.000 description 14
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 13
- 238000011084 recovery Methods 0.000 description 13
- 230000000052 comparative effect Effects 0.000 description 12
- 238000010792 warming Methods 0.000 description 12
- 238000004090 dissolution Methods 0.000 description 10
- NIPNSKYNPDTRPC-UHFFFAOYSA-N N-[2-oxo-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 NIPNSKYNPDTRPC-UHFFFAOYSA-N 0.000 description 9
- 239000002253 acid Substances 0.000 description 8
- -1 phosphoric acid (R) alpha-methyl benzyl Amine salt Chemical class 0.000 description 8
- 238000012360 testing method Methods 0.000 description 8
- 238000005352 clarification Methods 0.000 description 6
- 239000012065 filter cake Substances 0.000 description 6
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- MCSJGXLZPITMIH-UHFFFAOYSA-N 2-aminobutane-1,1,1-triol Chemical class CCC(N)C(O)(O)O MCSJGXLZPITMIH-UHFFFAOYSA-N 0.000 description 4
- 239000004593 Epoxy Substances 0.000 description 4
- 235000006408 oxalic acid Nutrition 0.000 description 4
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 3
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- KJIFKLIQANRMOU-UHFFFAOYSA-N oxidanium;4-methylbenzenesulfonate Chemical compound O.CC1=CC=C(S(O)(=O)=O)C=C1 KJIFKLIQANRMOU-UHFFFAOYSA-N 0.000 description 3
- 239000011574 phosphorus Substances 0.000 description 3
- 229910052698 phosphorus Inorganic materials 0.000 description 3
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- DOQWLDRSWPSNFJ-UHFFFAOYSA-N NC(C(O)(O)O)CC.CC1=CC=C(C=C1)S(=O)(=O)O Chemical compound NC(C(O)(O)O)CC.CC1=CC=C(C=C1)S(=O)(=O)O DOQWLDRSWPSNFJ-UHFFFAOYSA-N 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- SRSXLGNVWSONIS-UHFFFAOYSA-N benzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-N 0.000 description 2
- 229940092714 benzenesulfonic acid Drugs 0.000 description 2
- 239000003729 cation exchange resin Substances 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- QZIQJIKUVJMTDG-OTUWWBTESA-L disodium;[(2s,3r)-3-methyloxiran-2-yl]-dioxido-oxo-$l^{5}-phosphane Chemical compound [Na+].[Na+].C[C@H]1O[C@H]1P([O-])([O-])=O QZIQJIKUVJMTDG-OTUWWBTESA-L 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- DNIAPMSPPWPWGF-UHFFFAOYSA-N monopropylene glycol Natural products CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 2
- 150000003891 oxalate salts Chemical class 0.000 description 2
- XTUSEBKMEQERQV-UHFFFAOYSA-N propan-2-ol;hydrate Chemical compound O.CC(C)O XTUSEBKMEQERQV-UHFFFAOYSA-N 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- ZMZDMBWJUHKJPS-UHFFFAOYSA-N thiocyanic acid Chemical compound SC#N ZMZDMBWJUHKJPS-UHFFFAOYSA-N 0.000 description 2
- XUKUURHRXDUEBC-SXOMAYOGSA-N (3s,5r)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-ylpyrrol-1-yl]-3,5-dihydroxyheptanoic acid Chemical compound C=1C=CC=CC=1C1=C(C=2C=CC(F)=CC=2)N(CC[C@@H](O)C[C@H](O)CC(O)=O)C(C(C)C)=C1C(=O)NC1=CC=CC=C1 XUKUURHRXDUEBC-SXOMAYOGSA-N 0.000 description 1
- GOJUJUVQIVIZAV-UHFFFAOYSA-N 2-amino-4,6-dichloropyrimidine-5-carbaldehyde Chemical group NC1=NC(Cl)=C(C=O)C(Cl)=N1 GOJUJUVQIVIZAV-UHFFFAOYSA-N 0.000 description 1
- AAEQXEDPVFIFDK-UHFFFAOYSA-N 3-(4-fluorobenzoyl)-2-(2-methylpropanoyl)-n,3-diphenyloxirane-2-carboxamide Chemical compound C=1C=CC=CC=1NC(=O)C1(C(=O)C(C)C)OC1(C=1C=CC=CC=1)C(=O)C1=CC=C(F)C=C1 AAEQXEDPVFIFDK-UHFFFAOYSA-N 0.000 description 1
- 125000000590 4-methylphenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C([H])([H])[H] 0.000 description 1
- 241000254173 Coleoptera Species 0.000 description 1
- HNZOLQOUQFESFM-UHFFFAOYSA-N S(C)(=O)(=O)O.CNCC1=CC=CC=C1 Chemical compound S(C)(=O)(=O)O.CNCC1=CC=CC=C1 HNZOLQOUQFESFM-UHFFFAOYSA-N 0.000 description 1
- XSTXAVWGXDQKEL-UHFFFAOYSA-N Trichloroethylene Chemical compound ClC=C(Cl)Cl XSTXAVWGXDQKEL-UHFFFAOYSA-N 0.000 description 1
- 229940008309 acetone / ethanol Drugs 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- GDCXBZMWKSBSJG-UHFFFAOYSA-N azane;4-methylbenzenesulfonic acid Chemical compound [NH4+].CC1=CC=C(S([O-])(=O)=O)C=C1 GDCXBZMWKSBSJG-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 150000003939 benzylamines Chemical class 0.000 description 1
- 239000012069 chiral reagent Substances 0.000 description 1
- 230000006837 decompression Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 125000005909 ethyl alcohol group Chemical group 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 229960001806 fosfomycin trometamol salt Drugs 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 150000002561 ketenes Chemical class 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000005649 metathesis reaction Methods 0.000 description 1
- DGEYTDCFMQMLTH-UHFFFAOYSA-N methanol;propan-2-ol Chemical compound OC.CC(C)O DGEYTDCFMQMLTH-UHFFFAOYSA-N 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 229940039748 oxalate Drugs 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- ZNCPFRVNHGOPAG-UHFFFAOYSA-L sodium oxalate Chemical compound [Na+].[Na+].[O-]C(=O)C([O-])=O ZNCPFRVNHGOPAG-UHFFFAOYSA-L 0.000 description 1
- 229940039790 sodium oxalate Drugs 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 210000001635 urinary tract Anatomy 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
- C07F9/65502—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a three-membered ring
- C07F9/65505—Phosphonic acids containing oxirane groups; esters thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
- C07C213/08—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton by reactions not involving the formation of amino groups, hydroxy groups or etherified or esterified hydroxy groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
- C07C213/10—Separation; Purification; Stabilisation; Use of additives
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Saccharide Compounds (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710419776.0A CN108997425B (zh) | 2017-06-06 | 2017-06-06 | 一种制备高含量磷霉素氨丁三醇的方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710419776.0A CN108997425B (zh) | 2017-06-06 | 2017-06-06 | 一种制备高含量磷霉素氨丁三醇的方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN108997425A true CN108997425A (zh) | 2018-12-14 |
CN108997425B CN108997425B (zh) | 2020-11-13 |
Family
ID=64573013
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710419776.0A Active CN108997425B (zh) | 2017-06-06 | 2017-06-06 | 一种制备高含量磷霉素氨丁三醇的方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108997425B (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109608497A (zh) * | 2019-01-18 | 2019-04-12 | 科大华采(武汉)生物科技股份有限公司 | 一种磷霉素氨丁三醇的制备方法 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5162309A (en) * | 1989-07-27 | 1992-11-10 | Zambon Group | Mono (2-ammonium-2-hydroxymethyl-1,3-propanediol)(2r,cis)-1,2-ep-oxipropyl-phosphonate with improved characteristics of stability and processing |
ES2345591A1 (es) * | 2009-03-10 | 2010-09-27 | Labiana Pharmaceuticals, S.L. | Procedimiento para la preparacion de fosfomicina trometamol. |
CN102351902A (zh) * | 2011-08-12 | 2012-02-15 | 山西仟源制药股份有限公司 | 磷霉素单氨丁三醇的制备方法 |
CN102659842A (zh) * | 2012-04-18 | 2012-09-12 | 安徽赛诺医药化工有限公司 | 一种合成磷霉素氨丁三醇的新方法 |
CN104086592A (zh) * | 2014-07-22 | 2014-10-08 | 桂林华信制药有限公司 | 一种磷霉素氨丁三醇的制备方法 |
-
2017
- 2017-06-06 CN CN201710419776.0A patent/CN108997425B/zh active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5162309A (en) * | 1989-07-27 | 1992-11-10 | Zambon Group | Mono (2-ammonium-2-hydroxymethyl-1,3-propanediol)(2r,cis)-1,2-ep-oxipropyl-phosphonate with improved characteristics of stability and processing |
ES2345591A1 (es) * | 2009-03-10 | 2010-09-27 | Labiana Pharmaceuticals, S.L. | Procedimiento para la preparacion de fosfomicina trometamol. |
CN102351902A (zh) * | 2011-08-12 | 2012-02-15 | 山西仟源制药股份有限公司 | 磷霉素单氨丁三醇的制备方法 |
CN102659842A (zh) * | 2012-04-18 | 2012-09-12 | 安徽赛诺医药化工有限公司 | 一种合成磷霉素氨丁三醇的新方法 |
CN104086592A (zh) * | 2014-07-22 | 2014-10-08 | 桂林华信制药有限公司 | 一种磷霉素氨丁三醇的制备方法 |
Non-Patent Citations (1)
Title |
---|
李全 等: "光谱抗菌药磷霉素氨丁三醇的合成", 《中国医药工业杂志》 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109608497A (zh) * | 2019-01-18 | 2019-04-12 | 科大华采(武汉)生物科技股份有限公司 | 一种磷霉素氨丁三醇的制备方法 |
WO2020147160A1 (zh) * | 2019-01-18 | 2020-07-23 | 科大华采(武汉)生物科技股份有限公司 | 一种磷霉素氨丁三醇的制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN108997425B (zh) | 2020-11-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106187930B (zh) | 高纯度考布曲钙的制备方法 | |
CN102612563B (zh) | 一价琥珀酸盐的制备方法 | |
EP3845523B1 (en) | Synthesis method for cariprazine | |
CN108997424A (zh) | 一种简捷制备磷霉素氨丁三醇的方法 | |
CN111574456B (zh) | 一种Nα-叔丁氧羰基-L-组氨酸的合成方法 | |
CN109369430A (zh) | 一种制备6-氨基己酸的方法 | |
CN103467528A (zh) | 一种洛铂的制备方法 | |
CN112679498B (zh) | 磺酸季铵盐化合物及其制备方法和用途 | |
CN108997425A (zh) | 一种制备高含量磷霉素氨丁三醇的方法 | |
CN102875332A (zh) | 淤浆床低压法合成3-己炔-2,5-二醇的工艺 | |
US2768060A (en) | Manufacture of potassium bicarbonate by use of strongly basic amines | |
CN104086592B (zh) | 一种磷霉素氨丁三醇的制备方法 | |
CN110256370A (zh) | 一种帕瑞昔布钠的制备方法 | |
CN102603597A (zh) | (s)-奥拉西坦的制备方法 | |
CN106083689B (zh) | 一种赛洛多辛化合物的制备方法 | |
Renfrew et al. | Reactive dyes for cellulose. Concurrent methoxide‐hydroxide reactions of triazinyl reactive systems: a model system for assessment of potential fixation efficiency | |
CN113861204A (zh) | 酒石酸伐尼克兰片降解杂质的制备方法 | |
CN106831540B (zh) | 一种(s)-3-哌啶甲酸的制备方法 | |
CN109608497A (zh) | 一种磷霉素氨丁三醇的制备方法 | |
JPH04261189A (ja) | トリフルオロメタンスルホン酸スズの製造法 | |
CN112939789B (zh) | 一种甲基三丁基氯化铵制备方法 | |
CN111187255B (zh) | 右旋艾普拉唑钾盐的制备方法和右旋艾普拉唑的制备方法 | |
CN106674236B (zh) | 一种TMeQ[6]与D,L-谷氨酰胺超分子配合物及制备方法和应用 | |
CN111138293B (zh) | 一种用微通道反应器合成富马酸伊布利特中间体的方法 | |
US20230072446A1 (en) | Lithium selective organogels |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20200927 Address after: 139 No. 410203 Hunan province Changsha Wangcheng Tongguanshan circular economy industrial base Tongguan Road Applicant after: HUNAN HUANA LARGE PHARMACEUTICAL FACTORY CHIRAL MEDICAMENT Co.,Ltd. Applicant after: Hunan Warner Pharmaceutical Co., Ltd Address before: 139 No. 410203 Hunan province Changsha Wangcheng Tongguanshan circular economy industrial base Tongguan Road Applicant before: HUNAN HUANA LARGE PHARMACEUTICAL FACTORY CHIRAL MEDICAMENT Co.,Ltd. |
|
GR01 | Patent grant | ||
GR01 | Patent grant |